The Ethics of Meconium Testing as Part of a Screening Toolkit for FASD
The following information was part of session held in conjunction with the 12th Annual Fetal Alcohol Canadian Expertise (FACE) Research Roundtable on September 12th, at the Stanhope Beach Resort & Conference Centre, in Prince Edward Island.
Sponsored by: The Canadian Association of Paediatric Health Centres FASD Steering Committee and the Public Health Agency of Canada.
Dr. Stuart MacLeod, Professor, Paediatrics, Child and Family Research Institute, Faculty of Medicine, University of British Columbia
Dr. Gideon Koren, Professor of Paediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics, University of Toronto, National Lead – The Motherisk Program at The Hospital for Sick Children and Fetal Alcohol Canadian Expertise – FACE
Meconium Testing is one of the screening methods identified as part of the newly developed National Screening Tool Kit for Children and Youth. Meconium Testing has the capacity to identify fetal alcohol exposure through meconium sampling and testing post-natally. This symposium will explore various aspects and implications of meconium testing. Experts in related fields will present research as well as different perspectives on testing. Participants will have an opportunity to actively engage in discussion on the epidemiology of FASD, the What and Why of testing, results from recent Canadian studies and the ethical legal considerations related to meconium testing.
- Elaine Orrbine:
- Holly MacKay:
- Suzanne Tough MSc, PhD:
- Joey Gareri, M.Sc.:
- Moumita Sarkar, PhD:
- Kathryn Bigsby MD, FRCPC:
- Anna Zadunayski:
- Bernard M. Dickens LL.B., LL.M., Ph.D., LL.D: